Shares of Danaher Corp. DHR shed 1.34% to $212.13 Wednesday, on what proved to be an all-around favorable trading session for ...

Weidemanis' tenure as CEO will begin on March 12, 2025, following the company's Annual General Meeting of Shareholders.

Key Takeaways Johnson Controls shares led the S&P 500's gainers Wednesday morning after the company's first-quarter results ...

Argus lowered the firm’s price target on Danaher (DHR) to $260 from $300 and keeps a Buy rating on the shares after its Q4 earnings miss. The ...

Argus Research analyst David Toung maintained a Buy rating on Danaher (DHR – Research Report) yesterday. The company’s shares closed yesterday ...

Let's sort the S&P 500 healthcare sector again to show the 10 stocks with the highest percentages of "buy" or equivalent ratings. Only five companies are on both this list and the above growth list: ...

Danaher (NYSE:DHR – Get Free Report)‘s stock had its “market perform” rating reissued by research analysts at Raymond James ...

The Cranemere Group ("Cranemere" or the "Company"), a diversified holding company with permanent capital that enables long-term partnerships with companies, today announced the appointment of Jeff ...

Shares of Danaher Corp. DHR shed 3.81% to $214.26 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.76% to 5,994.57 and Dow ...

Fintel reports that on February 3, 2025, Raymond James downgraded their outlook for Danaher (NYSE:DHR) from Outperform to ...

We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...